10-100916695-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_018121.4(SLF2):c.310G>T(p.Val104Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000042 in 1,547,348 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_018121.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLF2 | ENST00000238961.9 | c.310G>T | p.Val104Leu | missense_variant | 3/20 | 1 | NM_018121.4 | ENSP00000238961.3 | ||
SLF2 | ENST00000370269.3 | c.310G>T | p.Val104Leu | missense_variant | 3/19 | 1 | ENSP00000359292.3 | |||
SLF2 | ENST00000370271.7 | c.310G>T | p.Val104Leu | missense_variant | 3/6 | 1 | ENSP00000359294.3 | |||
SLF2 | ENST00000649226.1 | n.310G>T | non_coding_transcript_exon_variant | 3/21 | ENSP00000496951.1 |
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152096Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000516 AC: 10AN: 193926Hom.: 0 AF XY: 0.0000580 AC XY: 6AN XY: 103450
GnomAD4 exome AF: 0.0000294 AC: 41AN: 1395134Hom.: 0 Cov.: 31 AF XY: 0.0000232 AC XY: 16AN XY: 689058
GnomAD4 genome AF: 0.000158 AC: 24AN: 152214Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74426
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 21, 2021 | The c.310G>T (p.V104L) alteration is located in exon 3 (coding exon 3) of the SLF2 gene. This alteration results from a G to T substitution at nucleotide position 310, causing the valine (V) at amino acid position 104 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at